Eye Care in Belgium

Eye Care in Belgium

Sales of eye care are usually dynamic but were slightly dampened by two negative factors in 2015. Firstly, the category was indirectly negatively impacted by the continuing success of eye care supplements, such as Preservision 3 from Bausch & Lomb and Nutrof Omega by Théa Pharma. Then, correlated with climatic conditions, allergy eye care often experienced irregular sales with frequent peaks and troughs. The first months of 2015 so were cold in comparison with the winter of 2014 that allergy...

Euromonitor International's Eye Care in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: Allergy Eye Care, Standard Eye Care.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Eye Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

EYE CARE IN BELGIUM
Euromonitor International
November 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Eye Care by Category: Value 2010-2015
Table 2 Sales of Eye Care by Category: % Value Growth 2010-2015
Table 3 Sales of Standard Eye Care by Format: % Value 2010-2015
Table 4 Sales of Standard Eye Care by Positioning: % Value 2010-2015
Table 5 NBO Company Shares of Eye Care: % Value 2011-2015
Table 6 LBN Brand Shares of Eye Care: % Value 2012-2015
Table 7 Forecast Sales of Eye Care by Category: Value 2015-2020
Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2015-2020
Janssen-cilag NV in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 1 Janssen-Cilag NV: Key Facts
Summary 2 Janssen-Cilag NV: Operational Indicators
Competitive Positioning
Summary 3 Janssen-Cilag NV: Competitive Position 2015
Executive Summary
Back To Normality Thanks To the Return of Bad Weather
Levels of Scrutiny Decline for Most Products
Belgian Players Lag Behind Multinationals But Often Fare Better
Distribution Remains Under the Control of Chemists/pharmacies Despite Some Changes
Mixed Prospects Overall for Consumer Health
Key Trends and Developments
Consumer Health Recovers, Although Not Thanks To the Local Economy
European and Local Legislation Seem To Unleash Some Products But Will Likely Continue To Dampen Sales
More Hectic Lifestyles Likely To Impact Sales
Dominant Multinationals Get Back Into the Race
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2010-2015
Table 10 Life Expectancy at Birth 2010-2015
Market Data
Table 11 Sales of Consumer Health by Category: Value 2010-2015
Table 12 Sales of Consumer Health by Category: % Value Growth 2010-2015
Table 13 NBO Company Shares of Consumer Health: % Value 2011-2015
Table 14 LBN Brand Shares of Consumer Health: % Value 2012-2015
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2010-2015
Table 16 Distribution of Consumer Health by Format: % Value 2010-2015
Table 17 Distribution of Consumer Health by Format and Category: % Value 2015
Table 18 Forecast Sales of Consumer Health by Category: Value 2015-2020
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2015-2020
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 4 OTC: Switches 2013-2015
Definitions
Sources
Summary 5 Research Sources












Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.